Physician profile
Guy Gregory Garrett
NPI 1851344006
$273.87
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.78 · 2020: $44.20 · 2021: $76.01 · 2022: $104.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $36.60 | 2022 | |
| Incyte Corporation | $34.78 | 2020-2022 | |
| Kyowa Kirin, INC. | $29.54 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.26 | 2022 | |
| Abbvie INC. | $28.33 | 2021 | |
| Rigel Pharmaceuticals, INC. | $19.64 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $19.21 | 2019 | |
| Seagen INC. | $18.38 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.54 | 2019 | |
| Amgen INC. | $15.18 | 2020 | |
| Astellas Pharma US INC | $13.88 | 2020 | |
| Beigene USA, INC. | $13.53 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.